Significant advancements have been made in medical research, such as the human body on chip technology that have the potential to better predict whether a drug will be safe and will work in humans than animal tests. But agencies such as the FDA must change their policies to allow more of these advancements to be used in place of artificial animal testing.
Join CCS in supporting the FDA Modernization Act of 2021
The FDA Modernization Act of 2021 amends the FFDCA by broadening options for drug development to include modern, innovative, human-relevant test methods. By doing so, this bill will speed up the discovery and lower the costs of new life-saving treatments.
In a major new development, the European Parliament resoundingly passed a resolution with a vote of 667 to 4 to phase out animal testing.
CCS welcomes two fantastic scientists who will lead the charge in supporting, promoting, and establishing the most innovative scientific tools that have the greatest ability to transform human health.
A curated list of scientific reports, white papers and videos for biomedical researchers and students on human-specific research methods, animal testing, and other relevant topics.
Sydney Lo, CCS's Science Intern, discusses her perspective on the lack of human-relevant testing methods throughout her academic career and the need to foster a future generation of scientists who understand the value of human-specific research methods in order to find the answers that animal models cannot give.
We’re proud to share that CCS has been recognized for its contribution to improve biomedical research by advancing human-specific research and testing methods.
Our Directory of Companies enables researchers, investors, and students to find collaborators to pioneer a paradigm shift towards testing methods that are based on human biology.
Our Directory of Academic Centers, including university-based initiatives and laboratories, enables researchers, investors, and students to find collaborators to pioneer a paradigm shift towards testing methods that are based on human biology.
Our Directory of Government and Nonprofit Agencies enables researchers, investors, and students to find collaborators to pioneer a paradigm shift towards testing methods that are based on human biology.
The Center for Contemporary Sciences announces the launch of a new international endeavor to improve human health: “Breakthroughs: Unlocking the Future of Medicine”.
The 2020 Annual Report for the Center of Contemporary Sciences
CCS is announcing a new partnership with GlassWall Syndicate to provide funding to companies developing alternatives to animal testing.
Dr. Akhtar discusses how the late Representative Alcee Hastings' legacy, the Humane Research and Testing Act (HRTA) of 2021, will provide a much needed boost to innovate biomedical science.
CCS is partnering with GlassWall Syndicate with an investment opportunity for companies developing alternatives to animal testing.
CCS is proud to announce its partnership with the GlassWall Syndicate to help drive investment toward the best, most effective medical research testing methods possible.
The COVID-19 pandemic is reshaping medicine, public health, and scientific research in an unprecedented way. This blog highlights three short-term and long-term impacts.
CCS's President and CEO, Dr. Aysha Akhtar, was interviewed on Pandemic Punditry Podcast episode titled "Animal Health is Human Health – Alternative to Animal Testing".
CCS Intern, Syama Patel, and Fellow, Mikalah Singer had a virtual “sit-down” with Dr. Kristen O’Halloran Cardinal from California Polytechnic State University to learn how students can get involved in innovative biomedical research.
Dr. Aysha Akhtar discusses the importance and effectiveness of human-specific biomedical research on "The Other Animals" Podcast.
Dr. Jarrod Bailey discussed "Minimizing Animal Models" with Dr. Ali Khademhosseini from The Terasaki Institute for Biomedical Innovation.
Academic researchers, along with representatives from the biotech industry and other stakeholders, meet to discuss the progress that has been made in in vitro biomedical sciences and technologies at the ACTC Conference.
Center for Contemporary Sciences' President and CEO, Dr. Aysha Akhtar, and Director of Science and Technology, Dr. Jarrod Bailey, discuss the importance of eliminating animal testing and focusing on innovative, biomedical research methods to improve human health.
This overview is intended to provide a snapshot of some salient and exciting developments and breakthroughs in various areas of biomedical research.
Researchers at Michigan State University (MSU) have grown the first functioning mini human heart model. As discussed in a recently published study, the model includes all the primary heart cell types, as well as functioning chamber structures and vascular tissue.
FOR IMMEDIATE RELEASE: Center for Contemporary Sciences Launches to Advance Human-Specific Research Models that will End Animal Testing.
In February 2019, a team of visionaries, scientists, and policy, non-profit and business leaders convened at a workshop at Harvard Law School to ask how can we help create a momentous shift in medical research in a way that betters human health and that replaces harmful experiments on animals.
The field of human-based research technologies is rapidly growing. For those interested in learning about where the latest developments are occurring, they must dig through volumes of literature and conduct in-depth and time-consuming internet and library searches. CCS is currently developing three Scientific Research Databases that will be freely available online.
The pandemic has created an immediate need to produce a safe vaccine—a process that researchers say can take upwards of 20 years. Is animal testing slowing us down?